- When Natural Disasters Strike, Another Crisis Hits Those Recovering From Opioid Addiction
- States Rush To Figure Out How To Enforce Trump’s Medicaid Work Requirements
- Cigna posts $1.65B in profit in Q1 earnings beat
- Bayer earns FDA untitled letter for Nubeqa's 'attention-grabbing visuals'
- Avalyn heads to Nasdaq with oversized $300M IPO to fund reformulated respiratory drugs
- Maine law increases oversight of healthcare transactions: 6 notes for dental leaders
- Align Technology sees 6.2% increase in Q1 revenue: 7 notes
- Aidoc banks $150M backed by Goldman Sachs to scale clinical AI foundation model
- 8 behavioral healthcare M&A deals in 2026
- Maryland autism therapy provider expands in-home services in Colorado
- 5 ways insurers are betting big on AI
- AHA warns of Chinese cyber actors using covert networks
- Will AI anxiety drive a new wave of talent to health systems?
- ‘There are no easy solutions’: What dental leaders told us in April
- 4 ways to improve hospital at home
- Connecticut House passes bill authorizing at-home dental hygiene visits
- Virtua Health eliminates 15K excess hospital days with Microsoft AI
- Delaware physician to pay $180K to settle fraud allegations
- UHS deployed 8 AI solutions in revenue cycle in 2025, eyes clinical operations
- Houston Methodist ranked most innovative health system in US — here’s how its leaders define that
- Tennessee specialist group joins Maury Regional Medical Group
- ‘Take the robot out of the human’: Health systems redeploy staff in the AI era
- New Jersey ASC performs robotic spine surgery milestone
- Aviation, hospitality and the NFL: What dentistry can learn from other industries
- HCA California system names COO
- Virginia expands noncompete limits for terminated employees
- Over half of dental professionals dealing with burnout: Report
- Parkview Health breaks ground on freestanding ED, urgent care facility
- Jefferson Health lands $1.7M grant for hypertension care
- 22 behavioral health executive moves to know
- The ‘significant opportunity’ Talkspace will bring to UHS
- Physician lawsuit rates hit historic lows, but malpractice premiums are soaring: AMA
- The potential ‘litigation wave’ headed for GI
- ASCs’ multi-billion dollar savings potential
- Dental’s new cash-pay anesthesia opportunity
- The new cash-pay anesthesia opportunity
- Healthcare costs remain a top concern for voters as midterms loom: KFF
- UHS-owned behavioral health facility to lay off 648 employees
- PeaceHealth physician group switch-up heads to court
- Novartis rounds out $23B US investment push with plans for North Carolina API plant
- Teladoc Health reports strong momentum behind BetterHelp insurance shift, CEO says
- Georgia Southern University to begin construction of new dental school
- AI Tool May Help Identify ADHD in Kids Long Before Typical Diagnosis
- Tennessee dental school to open clinic in Kentucky
- Federal autism committee outlines policy, care gaps in HHS letter
- Tennessee provider expands virtual behavioral health urgent care
- Chicago invests $16.2M in mental health, street psychiatry program
- US suicide rate declines 2%: 5 things to know
- FDA Moves to Real-Time Clinical Trial Patient Monitoring, Faster Drug Review
- AstraZeneca CEO's conservative MFN model excludes reference markets from forecast
- With Austedo at helm, Teva's impressive innovative drug sales signal company's successful metamorphosis
- Universal Health Services' Q1 2026 earnings growth dampened by volume hits
- AbbVie outlines Skyrizi defense against new J&J plaque psoriasis rival Icotyde
- Regeneron's quarterly sales of Eylea drop below $1B for the first time in 8 years
- Only 1 in 4 employers able to ‘absorb’ increasing health benefit costs without impacting business
- Dementia Screening Safe For Families, Trial Finds
- Online Program Soothes Post-Trauma Stress In Injured Children
- Mental Defeat Can Worsen Chronic Pain, Researchers Say
- Pooled Umbilical Cord Blood Boosts Stem Cell Transplant Success, Trial Finds
- New GSK CEO’s first quarter boosted by Shingrix surge as Exdensur stumbles in switch trial
- AstraZeneca restarts £300M investment in UK, but Merck not budging
- Chiesi lays out $1.9B to bolster rare disease offerings with KalVista buyout
- US drugmaker’s reputations shift quickly amid political pressures, job cuts: survey
- Saving Lives by Changing Lives: The Next Frontier in Suicide Prevention
- Trump’s Medicaid Work Mandate Debuting in Nebraska to Much Dismay
- Pfizer looks to jump start Elrexfio with topline win in second-line myeloma
- The push to expand access to emergency contraception
- Humana pulls back the curtain on planning for 2027 MA bids
- Lawmakers introduce bill to expand mental health clinics
- What 5 dentists would do differently in their careers
- On Capitol Hill, health system CEOs agree to 'rational reworking' of site-neutral payments
- Novartis CEO calls for 'complete rethink' of Europe's drug pricing policies
- Secret to Surviving 'Perfect Mom' Posts on Social Media Revealed
- Pfizer’s victory in delaying Vyndamax generics is mixed bag for BridgeBio: analysts
- Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Getting All Your Ducks in a Row to IPO: Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Remarks to the Small Business Capital Formation Advisory Committee
- FDA flags concerns for AstraZeneca's camizestrant, Truqap ahead of advisory committee meeting
- CDC Warns of Antibiotic-Resistant Salmonella in Backyard Flocks
- Listen to the Latest ‘KFF Health News Minute’
- AI-driven coding platform Arintra rolls out new documentation improvement capabilities
- Florida Delays Children's Health Insurance Expansion as Uninsured Rate Rises
- Interoperability was Never the Finish Line in Healthcare
- Interoperability was Never the Finish Line in Healthcare
- IKS Health to acquire TruBridge in $557M deal
- FDA turns up heat on Amgen, proposing to rescind approval of Tavneos
- Rocket sells priority review voucher for $180M after Kresladi gene therapy approval
- Big companies position themselves for payday from $50B federal rural health fund
- AZ's Breztri nabs FDA asthma nod, adding fuel to blockbuster launch
- Haleon scores branding goal with star-studded soccer offensive
- Daylight Saving Time Fails to Boost Daily Steps, Study Finds
- Metabolic Syndrome Tied To Cancer Risk
- Mail-In Colon Cancer Test Kits Offer Affordable Screening
- U.S. Dentists Still Overprescribing Opioids Compared To Other Nations, Puerto Rico
- Novartis stands by $5B Pluvicto goal despite European regulatory setback, bispecific competition
- An Urgent Care Treated Her Allergic Reaction. An ER Monitored Her — For $6,700.
- Big Companies Position Themselves for Payday From $50B Federal Rural Health Fund
- Centene swings to $1.5B profit as Medicaid business improves even as ACA membership falls by 2 million
- CCS deploys enterprise-wide agentic AI across chronic care operations
- Utah Medical Licensing Board urges state to shut down Doctronic AI prescribing pilot
- Estrogen Patch Shortages Likely Driven By Empowered Women Seeking Relief, Expert Says
- GSK's Tesaro unit dealt pre-trial blow in Jemperli feud with AnaptysBio
- Medical professional liability premiums rise for 7th straight year
- UChicago Medicine, Artisight partner on system-wide rollout of smart hospital platform
- Solace Health expands care navigation services to commercially insured patients
- First Gene Therapy for Genetic Hearing Loss, Otarmeni, Gains FDA Approval
- Mundipharma, CorMedix eye antifungal expansion after Rezzayo trial win
- CMS Extends Medicare's Short-Term Bridge Program for GLP-1 Obesity Drug Coverage
- Humana's CenterWell, Mark Cuban Cost Plus Drugs partner to tackle employers' drug costs
- Astellas counts on new medicines to offset projected Xtandi decline in fiscal 2026
- AMA urges lawmakers to implement stronger safeguards for AI chatbots in mental health
- Blood Glucose Monitors Improve Control Among Type 2 Diabetes Patients
- Regaining Weight After Quitting Your GLP-1 Drug? A Simple Procedure Might Help, Study Says
- Late-Night Noshing Could Contribute To Stress-Related Bathroom Problems
- New Treatment Targets Unaddressed Major Symptom Of Depression Through Joy, Pleasure and Purpose
- Florida Delays Children’s Health Insurance Expansion as Uninsured Rate Rises
- The Help That Many Older Americans Need Most
- UnityAI builds out agentic AI for staffing operations to match outpatient clinicians with patient demand
- Why Pricier Olive Oil May Be Better For Your Brain
- Your Internal Signal to Stop Eating is More Complex Than Previously Thought
- Gounder Culls the News, From Ticks and AI to Who Might Lead CDC
- FDA Accelerates Action on Treatments for Serious Mental Illness Following Executive Order
- Green Lighting Capital Formation: Remarks at the SEC International Institute on Capital Formation
- With ‘lessons learned,’ Kite prepares to hit the ground running as next-gen CAR-T decision looms
- Former Tobacco Executive Takes CDC Role
- New Plan Could Speed Medicare Coverage for Innovative Devices
- Heated Socks Sold at Costco Recalled After Burn Reports
- First Measles Case of the Year Reported in New Jersey
- CMS, FDA Announce RAPID Coverage Pathway to Accelerate Device Reimbursement
- CMS, FDA Announce RAPID Coverage Pathway to Accelerate Device Reimbursement
- Does Motherhood Shield You From Stroke?
- These Fun Pursuits Help Middle-Aged Folks Protect Brain Health, Study Finds
- New Guidelines Highlight Behavioral Therapy For Insomnia
- Playing Pretend Provides Unexpected Benefits For Growing Kids
- New Survey Estimates 8 Million Americans Used Psilocybin in 2024
- Eye Photos Might Offer Early Warning Of Chronic Health Problems, AI Study Finds
- A look at payers' attitudes toward specialty drug management
- 988 Hotline Leads to Fewer Suicides Among Young People, Study Finds
- Drop in NIH Funding Delays Thousands of Studies
- U.K. Plans To Ban Cigarette Sales for Future Generations
- Website Helps Dementia Patients And Caregivers Bond, Reminisce
- Gene Cure For Inherited Deafness Effective, Long Lasting, Clinical Trial Finds
- New Treatment, Dato-DXd, Improves Survival for Aggressive Breast Cancer
- ER Study Finds Major Gaps in Measles Immunity
- Opening Remarks at the 32nd Annual International Institute for Securities Market Growth and Development
- Keynote Remarks at The Economic Club of Washington
- Rethinking Prior Authorization for Better Outcomes
- Statement on the Amendments to Form PF
- Update on the SEC’s Work Toward Treasury Clearing Implementation
- A look at the National Academy of Medicine’s Change Maker Accelerators Program
Barry Cadden, the former President of New England Compounding Center (NECC), was given a 10- to 15-year sentence by Judge Matthew McGivney, the Chief Judge for the 44th Circuit Court in Livingston County, Michigan:
Pharmacy exec sentenced in Michigan over deadly 2012 meningitis outbreak
By Nate Raymond - May 10, 2024May 10 (Reuters) - A former owner of a Massachusetts compounding pharmacy whose mold-tainted drugs sparked a deadly U.S. fungal meningitis outbreak in 2012 was sentenced on Friday to at least 10 years in prison for his role in the deaths of 11 Michigan residents.
Barry Cadden, the former president of New England Compounding Center (NECC), was sentenced by Judge Matthew McGivney in Howell, Michigan, after pleading no contest in March to involuntary manslaughter charges related to the 11 deaths.
The 10- to 15-year sentence will run concurrently with an already-imposed 14-1/2 year federal prison term that Cadden, 57, is serving after he was convicted in 2017 on racketeering and fraud charges related to misrepresentations he made to NECC customers about its drugs.
Federal prosecutors in Boston had also sought to convict Cadden of second-degree murder over 25 deaths nationally caused by mold-tainted steroids that Framingham, Massachusetts-based NECC produced. Jurors acquitted Cadden of those charges.
Michigan's attorney general subsequently brought charges in state court against Cadden and Glenn Chin, NECC's former supervisory pharmacist, who like Cadden was convicted of federal fraud charges but cleared at trial of second-degree murder.
"The families of these 11 victims will forever bear the weight of Mr. Cadden's greed and disregard for basic standards that caused this horrific tragedy," Michigan Attorney General Dana Nessel said in a statement.
Prosecutors said NECC produced the drugs in filthy and unsafe conditions and sold them to hospitals and clinics nationally. The outbreak sickened 793 patients, more than 100 of whom have died, federal prosecutors have said.
Cadden's sentence on Friday credited him for the more than 6-1/2 years he has already spent in custody, according to his lawyer, Gerald Gleeson. He had no further comment.
Charges in Michigan remain pending against Chin, who has pleaded not guilty and is serving a 10-1/2 year federal sentence.
Glenn Chin was the supervising pharmacist of the New England Compounding Center (NECC); an employee of Barry Cadden, the former President, who got a dime piece earlier this month:
Trial Date Set for Man Charged with Murder in Livingston County Fungal Meningitis Outbreak
By Danny Wimmer - May 20, 2024LANSING – Judge Matthew J. McGivney in the 44th Circuit Court in Livingston County set the trial for Glenn Chin, 56, of Canton, Massachusetts, for November 4, 2024. Chin faces 11 counts of second-degree murder for his alleged involvement in the deadly 2012 fungal meningitis outbreak.
“Eleven Michiganders tragically lost their lives as a result of a lack of concern for patient safety,” Nessel said. “My department looks forward to finally seeking justice for the victims and their families in court.”
Chin was the supervising pharmacist at the New England Compounding Center (NECC) in Framingham, Massachusetts. In 2012, a nationwide fungal meningitis outbreak resulted in 64 deaths, 11 of which occurred at the Michigan Pain Specialists Clinic (MPS) in Livingston County. Patients at the clinic were given epidural injections of the steroid methylprednisolone, which was compounded and produced at the NECC in Massachusetts and shipped to MPS. Donna Kruzich, Paula Brent, Lyn Laperriere, Mary Plettl, Gayle Gipson, Patricia Malafouris, Emma Todd, Jennie Barth, Ruth Madouse, Salley Roe, and Karina Baxter died as a result of being injected with the contaminated drug.
The Department alleges that Chin disregarded sterility procedures in the compounding of sterile medications, created fraudulent cleaning records, and falsified scientific testing results.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
Sponsors
J & DE Family Charitable Fund
Friends
of MHF
Kelly Grotendiek
Philip Harbach
Dale Johnson
Drs. Jeffrey and Joni Jones
Vickie Kahle
Tammy Kipen
Marlin & Kathy Klumpp
Melanie Kurdys
Ruth Nobel
Patrick Peterson
Stephanie Poortenga
Jeanne Smit
Ben and Hope Staal
John Tuinstra
Jacki VanHuis
Sandy Walker
Sign Up for MHF Insights to keep up on the latest in Michigan Health Policy
